Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of a<i>BRCA1</i>or<i>BRCA2</i>Mutation-Reference-Cited by-同舟云学术

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

Published:2001-07-26 Issue:4 Volume:345 Page:235-240
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Modan Baruch,Hartge Patricia,Hirsh-Yechezkel Galit,Chetrit Angela,Lubin Flora,Beller Uzi,Ben-Baruch Gilad,Fishman Amiram,Menczer Joseph,Struewing Jeffery P.,Tucker Margaret A.,Ebbers Sara M.,Friedman Eitan,Piura Benjamin,Wacholder Sholom

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM200107263450401

Reference28 articles.

1. MEASURING THE SEPARATE EFFECTS OF LOW PARITY AND ITS ANTECEDENTS ON THE INCIDENCE OF OVARIAN CANCER

2. Parity, age at first childbirth, and risk of ovarian cancer

3. Ovarian cancer, ovulation and side of origin

4. Cancer Incidence in a Cohort of Infertile Woman

Cited by 345 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Épidémiologie des tumeurs de l’ovaire;EMC - Gynécologie;2025-07

2. Bibliographical Connections for Semiparametric Analysis in Case-Control Studies on Gene-Environment Interactions;Journal of Data Science;2024-10-16

3. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients;BMC Cancer;2024-05-06

4. Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis;Cancer Epidemiology, Biomarkers & Prevention;2024-02-01

5. Progesterone Enhances Niraparib Efficacy in Ovarian Cancer by Promoting Palmitoleic-Acid-Mediated Ferroptosis;Research;2024-01